Next Article in Journal
Adherence to Eye Drops Usage in Dry Eye Patients and Reasons for Non-Compliance: A Web-Based Survey
Previous Article in Journal
Early Measurement of ROX Index in Intermediary Care Unit Is Associated with Mortality in Intubated COVID-19 Patients: A Retrospective Study
Previous Article in Special Issue
Pursuing More Aggressive Timelines in the Surgical Treatment of Traumatic Spinal Cord Injury (TSCI): A Retrospective Cohort Study with Subgroup Analysis
 
 
Article
Peer-Review Record

A New Subform? Fast-Progressing, Severe Neurological Deterioration Caused by Spinal Epidural Lipomatosis

J. Clin. Med. 2022, 11(2), 366; https://doi.org/10.3390/jcm11020366
by Thiemo Florin Dinger 1,*, Maija Susanna Eerikäinen 2, Anna Michel 1, Oliver Gembruch 1, Marvin Darkwah Oppong 1, Mehdi Chihi 1, Tobias Blau 3, Anne-Kathrin Uerschels 1, Daniela Pierscianek 1, Cornelius Deuschl 2, Ramazan Jabbarli 1, Ulrich Sure 1 and Karsten Henning Wrede 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
J. Clin. Med. 2022, 11(2), 366; https://doi.org/10.3390/jcm11020366
Submission received: 12 December 2021 / Revised: 3 January 2022 / Accepted: 10 January 2022 / Published: 12 January 2022
(This article belongs to the Special Issue Types of Plegia Paralysis in a Spinal Cord Injury)

Round 1

Reviewer 1 Report

The manuscript “A New Subform?–Fast-Progressing, Severe Neurological Deterioration Caused by Spinal Epidural Lipomatosis”  is an article that aimed to widen current knowledge about this “SEL- subform” and to improve its clinical management.

Below are my comments and remarks regarding the article:

1. What was the time from the onset of symptoms to surgical intervention?
2. What was the preoperative procedure.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

Thank you to the authors for their interesting review of the literature on a challenging pathology to treat.  The content seem OK but there are a lot of typos.

 

For fig 2 it would be helpful to tell us if there is significant  statistical difference in the amount of epidural fat for asymptomatic versus symptomatic.   Also can you describe the software used to calculate the volume so it may used at other centers.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Round 2

Reviewer 2 Report

Thank you for your corrections and contribution to the literature.  

This manuscript is a resubmission of an earlier submission. The following is a list of the peer review reports and author responses from that submission.


Back to TopTop